The global Peri-Implantitis Treatment Market stands at US$ 2.3 Bn as of now and is expected to reach US$ 4.5 Bn by 2032 at a CAGR of 8.7% between 2022 and 2032. NCBI (National Center for Biotechnology Information) says that an average follow-up of 24 months all over the US accounts for 21% of market share at …